CD40 and glioblastoma: CD40 signaling also results in (1) enhanced glioblastoma multiforme (GBM) invasiveness, clonogenicity, and temozolomide resistance [58], and (2) the production of angiogenic factors (e.g., vascular endothelial growth factor [VEGF]) that promote tumor growth via neovascularization [59].